利用数字医疗技术在全球范围内优化抗菌药物的使用。

IF 23.8 1区医学 Q1 MEDICAL INFORMATICS

Lancet Digital Health Pub Date : 2024-11-14 DOI:10.1016/S2589-7500(24)00198-5

Timothy M Rawson PhD , Nina Zhu PhD , Ronald Galiwango PhD , Derek Cocker PhD , Mohammad Shahidul Islam PhD , Ashleigh Myall PhD , Vasin Vasikasin MD , Richard Wilson MPharm , Prof Nusrat Shafiq PhD , Prof Shampa Das PhD , Prof Alison H Holmes MD

{"title":"利用数字医疗技术在全球范围内优化抗菌药物的使用。","authors":"Timothy M Rawson PhD , Nina Zhu PhD , Ronald Galiwango PhD , Derek Cocker PhD , Mohammad Shahidul Islam PhD , Ashleigh Myall PhD , Vasin Vasikasin MD , Richard Wilson MPharm , Prof Nusrat Shafiq PhD , Prof Shampa Das PhD , Prof Alison H Holmes MD","doi":"10.1016/S2589-7500(24)00198-5","DOIUrl":null,"url":null,"abstract":"<div><div>Digital health technology (DHT) describes tools and devices that generate or process health data. The application of DHTs could improve the diagnosis, treatment, and surveillance of bacterial infection and the prevention of antimicrobial resistance (AMR). DHTs to optimise antimicrobial use are rapidly being developed. To support the global adoption of DHTs and the opportunities offered to optimise antimicrobial use consensus is needed on what data are required to support antimicrobial decision making. This Series paper will explore bacterial AMR in humans and the need to optimise antimicrobial use in response to this global threat. It will also describe state-of-the-art DHTs to optimise antimicrobial prescribing in high-income and low-income and middle-income countries, and consider what fundamental data are ideally required for and from such technologies to support optimised antimicrobial use.</div></div>","PeriodicalId":48534,"journal":{"name":"Lancet Digital Health","volume":"6 12","pages":"Pages e914-e925"},"PeriodicalIF":23.8000,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Using digital health technologies to optimise antimicrobial use globally\",\"authors\":\"Timothy M Rawson PhD , Nina Zhu PhD , Ronald Galiwango PhD , Derek Cocker PhD , Mohammad Shahidul Islam PhD , Ashleigh Myall PhD , Vasin Vasikasin MD , Richard Wilson MPharm , Prof Nusrat Shafiq PhD , Prof Shampa Das PhD , Prof Alison H Holmes MD\",\"doi\":\"10.1016/S2589-7500(24)00198-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Digital health technology (DHT) describes tools and devices that generate or process health data. The application of DHTs could improve the diagnosis, treatment, and surveillance of bacterial infection and the prevention of antimicrobial resistance (AMR). DHTs to optimise antimicrobial use are rapidly being developed. To support the global adoption of DHTs and the opportunities offered to optimise antimicrobial use consensus is needed on what data are required to support antimicrobial decision making. This Series paper will explore bacterial AMR in humans and the need to optimise antimicrobial use in response to this global threat. It will also describe state-of-the-art DHTs to optimise antimicrobial prescribing in high-income and low-income and middle-income countries, and consider what fundamental data are ideally required for and from such technologies to support optimised antimicrobial use.</div></div>\",\"PeriodicalId\":48534,\"journal\":{\"name\":\"Lancet Digital Health\",\"volume\":\"6 12\",\"pages\":\"Pages e914-e925\"},\"PeriodicalIF\":23.8000,\"publicationDate\":\"2024-11-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Lancet Digital Health\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2589750024001985\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICAL INFORMATICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lancet Digital Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2589750024001985","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICAL INFORMATICS","Score":null,"Total":0}

引用次数: 0

摘要

数字健康技术（DHT）是指生成或处理健康数据的工具和设备。数字健康技术的应用可以改善细菌感染的诊断、治疗和监测，并预防抗菌素耐药性（AMR）。用于优化抗菌药物使用的 DHT 正在迅速发展。为了支持在全球范围内采用 DHTs 并利用其提供的机会优化抗菌药物的使用，需要就支持抗菌药物决策所需的数据达成共识。本系列论文将探讨人类的细菌性 AMR 以及优化抗菌药使用以应对这一全球性威胁的必要性。它还将介绍在高收入和中低收入国家优化抗菌药物处方的最先进的 DHT 技术，并探讨这些技术需要哪些理想的基础数据来支持抗菌药物的优化使用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Using digital health technologies to optimise antimicrobial use globally

Digital health technology (DHT) describes tools and devices that generate or process health data. The application of DHTs could improve the diagnosis, treatment, and surveillance of bacterial infection and the prevention of antimicrobial resistance (AMR). DHTs to optimise antimicrobial use are rapidly being developed. To support the global adoption of DHTs and the opportunities offered to optimise antimicrobial use consensus is needed on what data are required to support antimicrobial decision making. This Series paper will explore bacterial AMR in humans and the need to optimise antimicrobial use in response to this global threat. It will also describe state-of-the-art DHTs to optimise antimicrobial prescribing in high-income and low-income and middle-income countries, and consider what fundamental data are ideally required for and from such technologies to support optimised antimicrobial use.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Lancet Digital Health Multiple-

CiteScore

41.20

自引率

1.60%

发文量

232

审稿时长

13 weeks

期刊介绍： The Lancet Digital Health publishes important, innovative, and practice-changing research on any topic connected with digital technology in clinical medicine, public health, and global health. The journal’s open access content crosses subject boundaries, building bridges between health professionals and researchers.By bringing together the most important advances in this multidisciplinary field,The Lancet Digital Health is the most prominent publishing venue in digital health. We publish a range of content types including Articles,Review, Comment, and Correspondence, contributing to promoting digital technologies in health practice worldwide.